Please login to the form below
vaccines
This page shows the latest vaccines news and features for those working in and with pharma, biotech and healthcare.
Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
The 12 NMEs – all said to be either first- or best-in-class – span oncology, rare diseases, neuroscience, gastro-enterology and vaccines – will be followed by a second wave of therapies ... Dengue vaccine TAK-003:Takeda’s dengue fever vaccine
Latest news
-
MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
Its recent investments in manufacturing reflect that shift, and have been pitched at improving capacity for Keytruda and other growth products like human papillomavirus (HPV) vaccine Gardasil 9, which has been
-
Merck claims first-ever okay for Ebola vaccine, in Europe
Another vaccine – MVA-BN-Filo from Bavarian Nordic – is in late-stage testing in Uganda. ... continue to produce V920 to supply compassionate-use programmes in the DRC assisted by the WHO, US government and vaccine charity Gavi.
-
J&J catches up to Merck, files Ebola vaccine in Europe
Now, J&J is looking to catch up – it is seeking licensure for its own investigational Ebola vaccine regimen in Europe. ... said Johan Van Hoof, global therapeutic area head, vaccines and managing director, Janssen vaccines &prevention.
-
Takeda’s dengue vaccine seems safe with no prior virus exposure
Appears unaffected by serious safety issue affecting Sanofi rival. Takeda says new data shows its candidate vaccine for dengue fever TAK-003 is effective, and crucially doesn’t seem to be ... Nevertheless for now it’s so far, so good for Takeda’s
-
GSK boosts outlook thanks to strong respiratory and vaccine sales
Key Q3 drivers include Shingrix vaccine and asthma drug Nucala. GlaxoSmithKline has raised its profit forecast for the second consecutive quarter thanks to the strong sales of its shingles vaccine Shingrix ... Also bringing the forecast up is GSK’s
More from news
Approximately 103 fully matching, plus 1,026 partially matching documents found.
Latest Intelligence
-
We’ll need more than a spoonful of sugar to counter vaccine hesitancy
Vaccine hesitancy. A delay in the acceptance or a refusal of vaccines despite availability of vaccination services (vaccine hesitancy) is a crucial element in the rise of vaccine refusal. ... Last year’s report by the London School of Hygiene and
-
Biotech profile: Tom Evans, CEO, Vaccitech.
The second development pathway is as an adjunct for seasonal vaccines to boost efficacy to levels higher than those achieved by the seasonal vaccine alone. ... You have a broad pipeline of candidates, including therapeutic vaccines, such as your vaccine
-
Crossing the digital divide between big pharma and real-world patients
Specifically in the healthcare space, a recent Royal Society for Public Health report highlighted that two in five parents are exposed to negative messages about vaccines on social media, and found
-
The UK’s new medicines pricing deal – opportunities and risks for pharma
There are also exemptions in what gets considered, including exceptional central procurements, vaccines, small company sales and low value sales.
-
Combining therapies and combining research
Of course, other strategies also play their part: improved antibiotic stewardship, good infection control, publicity about AMR, more effective vaccines, less use of antibiotics in agriculture, fast diagnostic testing, more professionals
More from intelligence
Approximately 6 fully matching, plus 83 partially matching documents found.
Latest appointments
-
New hires at Bayer, Eisai and Accord Healthcare
Most recently, she held the position of vice president of M&A operations and divestitures and led the infectious diseases and vaccines business development. ... She joins Eisai from Merck, where she served as executive director, clinical quality assurance
-
Bone Therapeutics strengthens board with new chairman
He has also been a member of the corporate executive team for GlaxoSmithKline and chief executive officer of GSK Biologicals (now GSK Vaccines).
-
McCann Health appoints Daniel Carucci as global medical director
Dr Carucci has over 25 years of experience in large-scale innovation programs, vaccine development, organisational leadership, and global public health, during which time he served as VP for global health
-
Professor Carole Longson moves from NICE to the ABPI
and the role our members play in developing new innovative medicines and vaccines.
-
Lilly bolsters its oncology team
Furthermore, she has been on the forefront of research in oncology vaccines, immuno-oncology and biosimilars, giving her the unique expertise that will be pivotal in helping us continue to develop
More from appointments
Approximately 5 fully matching, plus 62 partially matching documents found.
Latest from PMHub
-
UK vs US: what makes a successful immunisation programme?
The chickenpox vaccine, for example, was recommended for the US schedule by ACIP in 1996. ... I did manage to get the chickenpox vaccine for Anna when I was last in the USA.
-
Mergers and acquisitions: agents for change
From the $63 billion AbbVie-Allergan merger currently in play, to the BMS-Celgene merger earlier this year, division sales such as the transfer of Novartis vaccines unit to GSK, or
-
The impossible launch
th. century, those who discovered insulin, antibiotics, IVF, polio vaccine, the contraceptive pill to name a few, have made incredible positive changes to people’s lives across the planet.
-
Cello Health launches ‘Cello Health GmbH’ with new Berlin office and appointment of two regional directors to lead the Business Insights and Analytics division in Germany.
Heike Tombrink brings to Cello Health Insight more than 20 years of expertise as a strategic market research consultant, having worked internationally for Pharma (RX, OTC, Vaccines), Medical Supplies and MedTech
-
Fake News is Bad for your Health
Trust in vaccines fell as a result of emotional contagion, triggered by the 1998 publication of Andrew Wakefield's paper in the Lancet linking the MMR vaccine with autism and bowel ... Openness and transparency build credibility. Education on vaccines
More from PMHub
Approximately 4 fully matching, plus 27 partially matching documents found.
Featured jobs
-
Account Director
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Entry Level Editorial Assistant – Medical Education –Buckinghams...
-
Highly Competitive
- Scientific Director - Medical Communications - Berkshire
-
Excellent package on offer
-
Senior Medical Writer
-
Salary TBC
-
Account Supervisor
-
Salary TBC
- Senior Editor - Medical Communications - South East - Buckingham...
-
Highly competitive salary &package
-
Account Executive
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
Subscribe to our email news alerts
- The first of many celebrations for Lucid Group at Middlesex House
- FDA advisors say no to empagliflozin in type 1 diabetes
- Roche’s Spinraza, Zolgensma rival risdiplam hits the mark in SMA
- MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
- Novartis makes case for NASH candidate tropifexor
- Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
- RWE Blog 3: Is real-world evidence the holy grail
- What do Healthcare Professionals think about the inclusion of remote selling techniques?
- Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
- BeiGene bags FDA approval for first product Brukinsa in lymphoma
- Amarin wins FDA advisory nod for Vascepa cardiovascular expansion
- Shionogi scores FDA approval for new cUTI antibiotic
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- RWE Blog 3: Is real-world evidence the holy grail
- We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
- What do Healthcare Professionals think about the inclusion of remote selling techniques?
- Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
- Strengthening business competition and reducing anti-competitive practices
- How the CMA is tackling high prices for essential drugs...
Quick links
Infographics
